[Enzyme therapy in Fabry disease: when scarcity of one enzyme illustrates the vulnerability of biotech]

MeSH terms

• Adolescent
• Adult
• Biotechnology*
• Drug and Narcotic Control
• Enzyme Replacement Therapy*
• European Union
• Fabry Disease / drug therapy*
• Female
• Humans
• Isoenzymes / supply & distribution
• Isoenzymes / therapeutic use
• Male
• Orphan Drug Production
• alpha-Galactosidase / supply & distribution
• alpha-Galactosidase / therapeutic use*